Global Enteral Feeding Formulas Market Report, 2019: Analysis & Forecast, 2017 to 2026 - ResearchAndMarkets.com

DUBLIN--()--The "Enteral Feeding Formulas - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

According to this research, the Global Enteral Feeding Formulas market accounted for $4.29 billion in 2017 and is expected to reach $9.83 billion by 2026 growing at a CAGR of 9.7% during the forecast period.

Some of the key factors influencing the market growth include rising prevalence of chronic diseases and disorders, growing geriatric population, growing number of preterm births and rising demand for homecare. However, complications associated with enteral feeding are hindering the market growth.

Amongst Product, the standard formulas segment has considerable growth during the forecast period. The growth of this segment can be attributed to their extensive use in a majority of enterally fed patients, especially chronically tube-fed patients.

By Geography, Asia-Pacific region is expected to offer significant growth opportunities for market players during the forecast period due to the presence of a large patient pool for chronic diseases and disorders, increasing incidences of preterm births, rising healthcare expenditure, rapidly developing healthcare infrastructure, increasing middle-class population and rising population in emerging APAC countries.

Some of the key players in global enteral feeding formulas market are Abbott Laboratories, Novartis AG, Global Health Product Inc., Nestle S.A., Trovita Health Science, Danone Nutricia, Fresenius Kabi, Hormel Foods Corporation, Meiji Holdings Co., Ltd., Mead Johnson Nutrition Company, Victius Inc., B. Braun Melsungen AG and Merck & Co., Inc.

What the report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Key Topics Covered

1 Executive Summary

2 Preface

2.1 Abstract

2.2 Stake Holders

2.3 Research Scope

2.4 Research Methodology

2.4.1 Data Mining

2.4.2 Data Analysis

2.4.3 Data Validation

2.4.4 Research Approach

2.5 Research Sources

2.5.1 Primary Research Sources

2.5.2 Secondary Research Sources

2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Product Analysis

3.7 Application Analysis

3.8 End User Analysis

3.9 Emerging Markets

3.10 Futuristic Market Scenario

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Enteral Feeding Formulas Market, By Product

5.1 Introduction

5.2 Disease-Specific Formulas

5.2.1 Hepatic Formulas

5.2.2 Renal Formulas

5.2.3 Pulmonary Formulas

5.2.4 Liver Formulas

5.2.5 Immuno Modulatory Formulas

5.2.6 Gastrointestinal Dysfunction Formulas

5.2.7 Diabetic Formulas

5.2.8 Other Formulas

5.3 Standard Formulas

5.3.1 Monomeric Formulas

5.3.2 Polymeric Formulas

5.3.3 Calorie Dense Products

5.3.3.1 1.0 Calorie/ML

5.3.3.2 1.2 Calorie/ML

5.3.3.3 1.5 Calorie/ML

5.3.3.4 2.0 Calorie/ML

5.4 Blenderized Formula

5.4.1 Vegetables

5.4.2 Rice

5.4.3 Fruits

5.4.3.1 Avocado

5.4.3.2 Bananas

5.4.3.3 Raspberries

5.4.3.4 Sweet Potatoes

5.4.3.5 Strawberries

5.4.3.6 Quinoa

5.4.3.7 Blueberries

5.4.3.8 Other Fruits

5.4.4 Flax seed

5.4.5 Meat

5.4.6 Other Blenderized Formulas

5.5 Fiber Supplemented Formula

5.6 Semi-Elemental Formula

5.7 Polymeric Formula

5.8 Elemental Formula

5.9 Hydrolyzed Formula

5.10 Other Products

6 Global Enteral Feeding Formulas Market, By Stage

6.1 Introduction

6.2 Pediatrics

6.2.1 Oral Supplements

6.2.2 Tube Feeding Formulas

6.2.3 Infant Formulas

6.3 Adults

6.3.1 Modulars

6.3.2 Oral Supplements

6.3.3 Tube Feeding Formulas

7 Global Enteral Feeding Formulas Market, By Form

7.1 Introduction

7.2 Liquid

7.3 Powder

7.4 Other Forms

8 Global Enteral Feeding Formulas Market, By Mode of Delivery

8.1 Introduction

8.2 Oral

8.3 Trans-pyloric

8.3.1 Gastro-Jejunostomy

8.3.2 Naso-Jejunal

8.3.3 Jejunostomy

8.4 Gastric

8.4.1 Gastrostomy

8.4.2 Nasogastric

8.4.3 Oro-Gastric

9 Global Enteral Feeding Formulas Market, By Flavor Type

9.1 Introduction

9.2 Flavored

9.2.1 Vanilla

9.2.2 Butter Pecan

9.2.3 Strawberry

9.2.4 Other Flavors

9.3 Unflavored

10 Global Enteral Feeding Formulas Market, By Therapeutic Area

10.1 Introduction

10.2 Malabsorption

10.3 Crohn's disease

10.4 Cystic Fibrosis

10.5 Congenital Heart Disease

10.6 Kidney Failure

10.7 Choanal atresia

10.8 Inflammatory bowel disease

10.9 Short Bowel Syndrome

10.10 Other Therapeutic Areas

11 Global Enteral Feeding Formulas Market, By Application

11.1 Introduction

11.2 Gastroenterology

11.3 Diabetes

11.4 Neurology

11.5 Oncology

11.6 Critical Care

11.7 Other Applications

12 Global Enteral Feeding Formulas Market, By End User

12.1 Introduction

12.2 Long-Term Care Facilities

12.2.1 Assisted Living Facilities

12.2.2 Nursing Homes

12.2.3 Home Care Agencies and Hospices

12.3 Hospitals

13 Global Enteral Feeding Formulas Market, By Geography

13.1 Introduction

13.2 North America

13.2.1 US

13.2.2 Canada

13.2.3 Mexico

13.3 Europe

13.3.1 Germany

13.3.2 UK

13.3.3 Italy

13.3.4 France

13.3.5 Spain

13.3.6 Rest of Europe

13.4 Asia Pacific

13.4.1 Japan

13.4.2 China

13.4.3 India

13.4.4 Australia

13.4.5 New Zealand

13.4.6 South Korea

13.4.7 Rest of Asia Pacific

13.5 South America

13.5.1 Argentina

13.5.2 Brazil

13.5.3 Chile

13.5.4 Rest of South America

13.6 Middle East & Africa

13.6.1 Saudi Arabia

13.6.2 UAE

13.6.3 Qatar

13.6.4 South Africa

13.6.5 Rest of Middle East & Africa

14 Key Developments

14.1 Agreements, Partnerships, Collaborations and Joint Ventures

14.2 Acquisitions & Mergers

14.3 New Product Launch

14.4 Expansions

14.5 Other Key Strategies

15 Company Profiling

15.1 Abbott Laboratories

15.2 Novartis AG

15.3 Global Health Product Inc.

15.4 Nestle S.A.

15.5 Trovita Health Science

15.6 Danone Nutricia

15.7 Fresenius Kabi

15.8 Hormel Foods Corporation

15.9 Meiji Holdings Co. Ltd.

15.10 Mead Johnson Nutrition Company

15.11 Victius Inc.

15.12 B. Braun Melsungen AG

15.13 Merck & Co. Inc.

For more information about this report visit https://www.researchandmarkets.com/r/ije76y

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices